eMedicine Specialties > Dermatology > Diseases of the Dermis

Balanitis Xerotica Obliterans

Author: Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Coauthor(s): George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center; Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Contributor Information and Disclosures

Updated: Mar 17, 2008

Introduction

Background

Lichen sclerosus (LS) is a chronic, progressive, sclerosing inflammatory dermatosis of unclear etiology. Most reported LS cases (83%) involve the genitalia. In men, this genital involvement has traditionally been known as balanitis xerotica obliterans (BXO). A more accurate term is male genital or penile LS.

Yardley et al1 believe that the prevalence of BXO is greater than previous series have shown and that it may manifest in children at an earlier age than previous series have shown. This belief is based on a study of 422 boys at a median age of 6 years 2 months (range, 3 mo to 16 y), of whom 186 (44.1%) received treatment involving surgery (148 circumcision, 33 preputial adhesiolysis, 5 frenuloplasty). Of the 186 boys, 110 had histological tissue examination; 84.8% of skin samples were pathologic. Specifically, tissue showed chronic inflammation (n = 69; 46.6%), BXO (n = 51; 34.5%), and fibrosis (n = 4; 2.7%).

For related eMedicine articles, see Lichen Sclerosus et Atrophicus, Balanitis Circumscripta Plasmacellularis, and Balanitis. Also, Medscape's CME course HPV-Related Disease in Men: Anal and Penile Cancer (Slides With Transcript) may be of interest.

Pathophysiology

The etiology of male genital LS is unknown, but it is thought to be multifactorial. BXO has occurred in monozygotic twins, which suggests a genetic basis for the disease in some cases. Human papillomavirus type 6 or type 16 has not been detected in patients with BXO, which strongly suggests that genital papillomaviruses do not have a strong association with BXO.

Frequency

United States

Kizer et al2 noted that of 153,432 male patients discharged from Brooke Army Medical Center, 108 (0.070%) had a diagnosis of BXO. The age distribution was similar over a range of 2-90 years, with the exception of the third decade, when the incidence almost doubled. Black and Hispanic patients had twice the rate found in white patients (10.59 cases, 10.67 cases, and 5.07 cases per 10,000 patients, respectively).

International

The prevalence of male genital LS has traditionally been estimated at 1 case per 300-1000 males. No recent studies confirm this estimate, but male genital LS is not considered a rare condition. Huntley et al3 reported on 100 consecutive patients seen in pediatric urology clinics who were followed to discharge. Eighteen referrals for circumcision were for religious reasons. Of the other 82 patients, the main reason for referral was retractability or phimosis. Six patients were identified as having BXO, a condition that had not been suggested on referral.

Race

Male genital LS has no known predilection for any racial or ethnic group.

Sex

Male genital LS occurs most frequently in persons who are uncircumcised and who are of middle age. One study4 revealed that 51 (98%) of 52 patients clinically diagnosed with penile LS were uncircumcised.

Age

Although males with genital LS are most frequently of middle age, the condition also may appear in children, ranging from young boys to adolescents. The incidence of BXO in pediatric patients is higher than most physicians realize. Additionally, the incidence of BXO is high in boys with phimosis.5,6,7

Clinical

History

Early in its course, penile LS is relatively asymptomatic with only mild visually observable changes of the penis and glans. Physical changes occur over months or years and may include color or textural changes. Early symptoms are more prevalent in uncircumcised patients.

  • Symptoms occurring with time and progression of penile LS are as follows:
    • Pruritus
    • Burning
    • Hypoesthesia of the glans penis
    • Dysuria
    • Painful erection with altered sexual function
    • Decrease in urinary force or stream caliber
    • Urethritis with or without discharge
  • Symptoms occurring in late penile LS (in uncircumcised patients) are as follows:
    • Phimosis (inability to retract the foreskin over the glans)
    • Paraphimosis (inability to return an already retracted foreskin back over the glans)
  • The development of multifocal squamous cell carcinoma (SCC) in persons with LS et atrophicus of the penis and hepatitis C virus infection has been reported. SCC of the penis arising from BXO alone has also been noted.
  • A urethral stone manifesting as a stop valve, a rare complication of BXO, has been reported.

Physical

Early penile LS demonstrates only subtle physical findings (eg, mild, nonspecific erythema; mild hypopigmentation).

  • As the condition progresses, single or multiple discrete erythematous papules or macules progress and coalesce into atrophic ivory, white, or purple-white patches or plaques.
    • Lesions most commonly affect the glans and prepuce.
    • The frenulum, urethral meatus, fossa navicularis, penile shaft, and perianal areas may become involved.
    • A sclerotic white ring at the tip of the prepuce is diagnostic at this stage.
    • Erosions, fissures, petechiae, serous and hemorrhagic bullae, and telangiectasias of the glans have been reported, albeit uncommonly.
  • With further disease progression, the glans may become adherent to the prepuce.
    • The coronal sulcus and frenulum may be sclerotically destroyed.
    • The urethral meatus may narrow to the point of urinary retention.
    • Urinary retention may be severe enough to cause retrograde damage to the posterior urethra and to the bladder and kidneys.
    • Significant urethral meatal narrowing has led to sloughing of the distal half centimeter of the urethra.
    • Phimosis and paraphimosis of uncircumcised patients may occur at this late stage.
  • Seventeen percent of LS cases are extragenital, beginning as mild, nonspecific erythema with mild hypopigmentation.
  • In one case report8 , BXO in a middle-aged man involved the entire anterior urethra and the scrotum. It manifested as a palpable nodular scrotal mass and caused obstructive voiding symptoms. He was treated with a staged urethroplasty.

Causes

The etiology of male genital LS is unknown but is thought to be multifactorial. Several contributing factors are possible, as follows:

  • Circumcision after age 13 years/uncircumcised state
    • This may very well be due to the effect known as the isomorphic, or Koebner, phenomenon. The large majority of inflammatory dermatoses of the male genitalia, including LS, occur in uncircumcised or late-circumcised men.
    • The presence of a foreskin may promote chronic irritation or serve to maintain a friendly environment for an as-yet unidentified infectious agent. Such chronic irritation and subsequent inflammation may initiate the changes noted in LS.
  • Hormonal factors
    • Hormonal influences in the development of LS have long been postulated, mainly in female vulvar LS.
    • Most studies have concentrated on the role of testosterone in the pathogenesis of vulvar LS. Childhood vulvar LS frequently resolves with the onset of menarche and the related pubertal increase in testosterone production in genital skin; additionally, adults with LS have been found to have decreased serum levels of free testosterone, androstenedione, and dihydrotestosterone compared with control subjects.
    • The underlying defect may be a problem with the function of the enzyme 5-alpha reductase.
  • Autoimmune disease
    • Various autoantibodies (including antinuclear, thyroid antimicrosomal, antigastric parietal cell, anti-adrenal cortex, antismooth muscle, and antimitochondrial antibodies) have been detected in patients with LS.
    • Vitiligo, thyroid disease, diabetes, and alopecia areata have also been commonly reported in association with LS.
  • Genetic factors
    • LS (not necessarily genital LS) has been reported in families, including twins (identical and nonidentical), sisters, mothers and daughters, and a brother and sister.
    • Note, however, that no consistent pattern of genetic inheritance has been identified.
  • Presence of human papillomaviruses
    • The presence of human papillomaviruses (HPV) has been reported in some cases of childhood penile LS. Whether the LS is directly attributable to HPV infection, or if LS merely promotes HPV infection is unclear.
    • Patients with penile LS alone have not been demonstrated to have a higher incidence of HPV infection.
  • Other: In a study of 18 patients9 with combined buccal mucosa grafting and genital skin flap reconstruction of extensive anterior urethral strictures, 16.7% of stricture cases were caused by BXO.

More on Balanitis Xerotica Obliterans

Overview: Balanitis Xerotica Obliterans
Differential Diagnoses & Workup: Balanitis Xerotica Obliterans
Treatment & Medication: Balanitis Xerotica Obliterans
Follow-up: Balanitis Xerotica Obliterans
Multimedia: Balanitis Xerotica Obliterans
References

References

  1. Yardley IE, Cosgrove C, Lambert AW. Paediatric preputial pathology: are we circumcising enough?. Ann R Coll Surg Engl. Jan 2007;89(1):62-5. [Medline].

  2. Kizer WS, Prarie T, Morey AF. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med J. Jan 2003;96(1):9-11. [Medline].

  3. Huntley JS, Bourne MC, Munro FD, Wilson-Storey D. Troubles with the foreskin: one hundred consecutive referrals to paediatric surgeons. J R Soc Med. Sep 2003;96(9):449-51. [Medline].

  4. Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol. Mar 2000;136(3):350-4. [Medline].

  5. Chalmers RJ, Burton PA, Bennett RF, Goring CC, Smith PJ. Lichen sclerosus et atrophicus. A common and distinctive cause of phimosis in boys. Arch Dermatol. Aug 1984;120(8):1025-7. [Medline].

  6. Kiss A, Kiraly L, Kutasy B, Merksz M. High incidence of balanitis xerotica obliterans in boys with phimosis: prospective 10-year study. Pediatr Dermatol. Jul-Aug 2005;22(4):305-8. [Medline].

  7. Rossi E, Pavanello P, Franchella A. Lichen sclerosus in children with phimosis. Minerva Pediatr. Dec 2007;59(6):761-5. [Medline].

  8. Singh I, Ansari MS. Extensive balanitis xerotica obliterans (BXO) involving the anterior urethra and scrotum. Int Urol Nephrol. 2006;38(3-4):505-6. [Medline].

  9. Berglund RK, Angermeier KW. Combined buccal mucosa graft and genital skin flap for reconstruction of extensive anterior urethral strictures. Urology. Oct 2006;68(4):707-10; discussion 710. [Medline].

  10. Ebert AK, Vogt T, Rösch WH. Topical therapy of balanitis xerotica obliterans in childhood : Long-term clinical results and an overview. Urologe A. Dec 2007;46(12):1682-1686. [Medline].

  11. Kiss A. The response of clinical balanitis xerotica obliterans to the application of topical steroid-based creams. J Pediatr Surg. Mar 2006;41(3):606; author reply 606-7. [Medline].

  12. Ratz JL. Carbon dioxide laser treatment of balanitis xerotica obliterans. J Am Acad Dermatol. May 1984;10(5 Pt 2):925-8. [Medline].

  13. Dubey D, Sehgal A, Srivastava A, Mandhani A, Kapoor R, Kumar A. Buccal mucosal urethroplasty for balanitis xerotica obliterans related urethral strictures: the outcome of 1 and 2-stage techniques. J Urol. Feb 2005;173(2):463-6. [Medline].

  14. Levine LA, Strom KH, Lux MM. Buccal mucosa graft urethroplasty for anterior urethral stricture repair: evaluation of the impact of stricture location and lichen sclerosus on surgical outcome. J Urol. Nov 2007;178(5):2011-5. [Medline].

  15. Palminteri E, Berdondini E, Lazzeri M, Mirri F, Barbagli G. Resurfacing and reconstruction of the glans penis. Eur Urol. Sep 2007;52(3):893-8. [Medline].

  16. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol. Dec 2007;178(6):2268-76. [Medline].

  17. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. Dec 1999;41(6):911-4. [Medline].

  18. Drut RM, Gomez MA, Drut R, Lojo MM. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol. Mar-Apr 1998;15(2):85-90. [Medline].

  19. Goolamali SI, Pakianathan M. Penile carcinoma arising in balanitis xerotica obliterans. Int J STD AIDS. Feb 2006;17(2):135-6. [Medline].

  20. Bainbridge DR, Whitaker RH, Shepheard BG. Balanitis xerotica obliterans and urinary obstruction. Br J Urol. Aug 1971;43(4):487-91. [Medline].

  21. Beljaards RC, van Dijk E, Hausman R. Is pseudoepitheliomatous, micaceous and keratotic balanitis synonymous with verrucous carcinoma?. Br J Dermatol. Nov 1987;117(5):641-6. [Medline].

  22. Bingham JS. Carcinoma of the penis developed in lichen sclerosus et atrophicus. Br J Vener Dis. Oct 1978;54(5):350-1. [Medline].

  23. English JC 3rd, Laws RA, Keough GC, Wilde JL, Foley JP, Elston DM. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. Jul 1997;37(1):1-24; quiz 25-6. [Medline].

  24. Jenkins D Jr, Jakubovic HR. Pseudoepitheliomatous, keratotic, micaceous balanitis. A clinical lesion with two histologic subsets: hyperplastic dystrophy and verrucous carcinoma. J Am Acad Dermatol. Feb 1988;18(2 Pt 2):419-22. [Medline].

  25. Ledwig PA, Weigand DA. Late circumcision and lichen sclerosus et atrophicus of the penis. J Am Acad Dermatol. Feb 1989;20(2 Pt 1):211-4. [Medline].

  26. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. Mar 1995;32(3):393-416; quiz 417-8. [Medline].

  27. Meyrick Thomas RH, Ridley CM, Black MM. Clinical features and therapy of lichen sclerosus et atrophicus affecting males. Clin Exp Dermatol. Mar 1987;12(2):126-8. [Medline].

  28. Mikat DM, Ackerman HR Jr, Mikat KW. Balanitis xerotica obliterans: report of a case in an 11-year-old and review of the literature. Pediatrics. Jul 1973;52(1):25-8. [Medline].

  29. Peterson AC, Palminteri E, Lazzeri M, Guanzoni G, Barbagli G, Webster GD. Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (balanitis xerotica obliterans). Urology. Sep 2004;64(3):565-8. [Medline].

  30. Pietrzak P, Hadway P, Corbishley CM, Watkin NA. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated?. BJU Int. Jul 2006;98(1):74-6. [Medline].

  31. Read SI, Abell E. Pseudoepitheliomatous, keratotic, and micaceous balanitis. Arch Dermatol. Jul 1981;117(7):435-7. [Medline].

  32. Staff WG. Urethral involvement in balanitis xerotica obliterans. Br J Urol. Apr 1970;42(2):234-9. [Medline].

  33. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971;57(1):9-30. [Medline].

Further Reading

Keywords

BXO, penile lichen sclerosus, male genital lichen sclerosus, lichen sclerosus et atrophicus, LS, penile LS, sclerosing inflammatory dermatosis, Koebner phenomenon, vitiligo, thyroid disease, diabetes, alopecia areata,  pseudoepitheliomatous keratotic and micaceous balanitis, PKMB

Contributor Information and Disclosures

Author

Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Optigenex Consulting fee Independent contractor

Coauthor(s)

George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center
George C Keough, MD is a member of the following medical societies: American Academy of Dermatology and American Medical Association
Disclosure: Nothing to disclose.

Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Mark W Cobb, MD, Consulting Staff, WNC Dermatological Associates
Mark W Cobb, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Society of Dermatopathology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.